Clinical Microbiology Reviews

Papers
(The median citation count of Clinical Microbiology Reviews is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Board289
Editorial Board259
Editorial Board164
2022 Acknowledgment of CMR Reviewers151
Diagnosis, Management, and Future Control of Cholera146
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections123
Extracutaneous sporotrichosis122
Companions in antimicrobial resistance: examining transmission of common antimicrobial-resistant organisms between people and their dogs, cats, and horses117
Streptococcus dysgalactiae subsp. equisimilis infection and its intersection with Streptococcus pyogenes108
Beyond schistosomiasis: unraveling co-infections and altered immunity99
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection98
BCG therapy in bladder cancer and its tumor microenvironment interactions88
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease81
SARS-CoV-2 Antiviral Therapy79
Transmission of Infections during Cardiopulmonary Resuscitation79
2024 Acknowledgment of CMR Reviewers74
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials73
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond72
Natural-Product-Based Solutions for Tropical Infectious Diseases67
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease66
Recent development and fighting strategies for lincosamide antibiotic resistance62
Updated Review onNocardiaSpecies: 2006–202160
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections58
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility52
Monkeypox Virus Infections in Humans51
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence48
Osteoarticular Mycoses47
Human and Animal Fascioliasis: Origins and Worldwide Evolving Scenario46
Antiviral Approaches against Influenza Virus44
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders44
Toward better cures for Mycobacterium abscessus lung disease43
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections43
Rapid and accurate testing for urinary tract infection: new clothes for the emperor41
Invasive fusariosis41
Laboratory detection of carbapenemases among Gram-negative organisms40
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review39
Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy39
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases38
Staphylococcus capitis : insights into epidemiology, virulence, and antimicrobial resistance of a clinically relevant bacterial species37
Clinical Microbiology Reviews : a 21st century vision37
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management35
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes35
How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infectio33
Laboratory Detection of Malaria Antigens: a Strong Tool for Malaria Research, Diagnosis, and Epidemiology31
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections31
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”31
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices30
Aspergillus terreus Species Complex29
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance28
Enriching the future of public health microbiology with hybridization bait capture28
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management27
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection26
Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections25
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections25
The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases24
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective24
Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks24
Trained Immunity as a Preventive Measure for Surgical Site Infections23
Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections22
Host Immunity and Immunization Strategies for Clostridioides difficile Infection22
Artemisinin-resistant malaria21
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities20
Vaccines and monoclonal antibodies: new tools for malaria control19
Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments18
Editorial Board18
Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy17
Editorial Board16
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities15
Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases15
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases15
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant15
Persistent Borrelia burgdorferi Sensu Lato Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Model15
Erratum for Ramasamy and Subbian, “Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis”14
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)13
Harnessing the host response for precision infectious disease diagnosis13
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome13
Progression of antibiotic resistance in Neisseria meningitidis12
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus12
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream12
Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward12
Group B streptococcal infections in pregnancy and early life12
Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection11
Testing for SARS-CoV-2: lessons learned and current use cases10
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria10
Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use10
MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets10
SARS-CoV-2 Infection and Lung Regeneration10
0.24812793731689